Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.30
-0.0073-0.02%
Volume:5K
Turnover:172.54K
Market Cap:50.82M
PE:- -
High:31.78
Open:31.47
Low:31.21
Close:31.30
52wk High:32.89
52wk Low:23.48
Shares:1.62M
Float Shares:1.62M
Volume Ratio:0.77
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

10x Genomics CFO Adam Taich Sells USD 2.99 Million in Common Shares

Reuters
·
Sep 12

Revvity Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Parker Hannifin Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 11

10x Genomics partners with Korea-based Lunit for AI-enabled pathology analysis

TIPRANKS
·
Sep 10

Lunit - Announces Collaboration with 10x Genomics for AI Pathology and Spatial Molecular Data in Oncology

THOMSON REUTERS
·
Sep 10

Fortrea Reinstates Knoblauch as CFO After Legal Dispute with Former Employer

Dow Jones
·
Sep 10

Revvity Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Thermo Fisher Coverage Assumed by UBS at Buy vs Previous Rating of Neutral

Dow Jones
·
Sep 09

UBS Adjusts Price Target on 10x Genomics to $68 From $20, Keeps Neutral Rating

MT Newswires Live
·
Sep 09

U.S. Stocks on the MOVE-UGI, Chewy, Cognyte Software

Reuters
·
Sep 09

LifeStance Launches Secondary Offering, Concurrent Share Repurchase

MT Newswires Live
·
Sep 09

LifeStance 22.25M share Spot Secondary reoffered at $12.35

TIPRANKS
·
Sep 09

LifeStance Health Falls as PE Backers to Carve Stakes

Reuters
·
Sep 09

LifeStance announces 22.25M share offering of common stock for holders

TIPRANKS
·
Sep 09

Lifestance Health Group, - Authorizes Repurchase of 2,000,000 Shares from Underwriter

THOMSON REUTERS
·
Sep 09

Lifestance Health Group, - Announces Secondary Offering of 22,250,000 Shares by Selling Stockholders

THOMSON REUTERS
·
Sep 09

Lifestance Health Group Announces Launch of Secondary Public Offering

THOMSON REUTERS
·
Sep 09

LifeStance Health Group Announces Launch of Secondary Public Offering

GlobeNewswire
·
Sep 09

Qiagen Names Jonathan M. Pratt CEO, Effective Sept. 1, 2026

Reuters
·
Sep 09

Danaher assumed with a Buy at UBS

TIPRANKS
·
Sep 09